Basics Vincerx Pharma, Inc. Common Stock IPO Date: May 5, 2020 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.56% Avg Daily Range (30 D): $0.01 | 13.21% Avg Daily Range (90 D): $0.05 | 7.10% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): 1.03M Trade Size Avg Trade Size (Sh.): 430 Avg Trade Size (Sh.) (30 D): 1,129 Avg Trade Size (Sh.) (90 D): 405 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $1.76M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.86M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 16.22K         News Apr 9, 2025 @ 9:53 AM US Stocks Futures Trade Mixed Ahead Of Opening Bel... Source: Rishabh Mishra Mar 18, 2025 @ 12:52 PM Vincerx Pharma Announces Non-Binding Letter of Int... Source: Globe Newswire Feb 28, 2025 @ 9:05 PM Vincerx Pharma Announces Termination of Reverse Me... Source: Globe Newswire Jan 10, 2025 @ 2:55 PM SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ... Source: N/A Jan 10, 2025 @ 2:37 PM Kuehn Law Encourages VINC, NEUE, GETY, and CLBR In... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-16.84 $-1.4 $-15.22 Diluted EPS $-32.52 $-1.4 $-15.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -22.65M $ -5M $ -7.99M Operating Income / Loss $ -27.32M $ -3.33M $ -8.83M Cost of Revenue $ $ $ Net Cash Flow $ -7.77M $ -.05M $ 2.04M PE Ratio     Splits Jan 28, 2025:   1:20